These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
592 related articles for article (PubMed ID: 35974660)
21. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes. Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690 [TBL] [Abstract][Full Text] [Related]
22. Effects of Fish Oil and Grape Seed Extract Combination on Hepatic Endogenous Antioxidants and Bioactive Lipids in Diet-Induced Early Stages of Insulin Resistance in Rats. Taltavull N; Miralles-Pérez B; Nogués MR; Ramos-Romero S; Méndez L; Medina I; Torres JL; Romeu M Mar Drugs; 2020 Jun; 18(6):. PubMed ID: 32560216 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis. Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005 [TBL] [Abstract][Full Text] [Related]
29. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity. Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775 [TBL] [Abstract][Full Text] [Related]
30. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans. Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141 [TBL] [Abstract][Full Text] [Related]
31. The Presence of Periodontitis Exacerbates Non-Alcoholic Fatty Liver Disease via Sphingolipid Metabolism-Associated Insulin Resistance and Hepatic Inflammation in Mice with Metabolic Syndrome. Lu Z; Li Y; Chowdhury N; Yu H; Syn WK; Lopes-Virella M; Yilmaz Ö; Huang Y Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176029 [TBL] [Abstract][Full Text] [Related]
32. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related]
33. Role of liver FGF21-KLB signaling in ketogenic diet-induced amelioration of hepatic steatosis. Guo W; Cao H; Shen Y; Li W; Wang W; Cheng L; Cai M; Xu F Nutr Diabetes; 2024 Apr; 14(1):18. PubMed ID: 38609395 [TBL] [Abstract][Full Text] [Related]
34. The ketogenic diet maintains insulin sensitivity and inhibits lipid accumulation in the liver. King AN; Notaro NM J Physiol; 2022 Nov; 600(21):4543-4545. PubMed ID: 36161655 [No Abstract] [Full Text] [Related]
35. Effects of low-carbohydrate diet and ketogenic diet on glucose and lipid metabolism in type 2 diabetic mice. Yang Z; Mi J; Wang Y; Xue L; Liu J; Fan M; Zhang D; Wang L; Qian H; Li Y Nutrition; 2021 Sep; 89():111230. PubMed ID: 33838492 [TBL] [Abstract][Full Text] [Related]
36. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS. Song HM; Li X; Liu YY; Lu WP; Cui ZH; Zhou L; Yao D; Zhang HM Int J Mol Med; 2018 Jul; 42(1):193-207. PubMed ID: 29620148 [TBL] [Abstract][Full Text] [Related]
37. The effect of high fat diet and metformin treatment on liver lipids accumulation and their impact on insulin action. Zabielski P; Hady HR; Chacinska M; Roszczyc K; Gorski J; Blachnio-Zabielska AU Sci Rep; 2018 May; 8(1):7249. PubMed ID: 29739997 [TBL] [Abstract][Full Text] [Related]
38. Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice. Yano K; Yamaguchi K; Seko Y; Okishio S; Ishiba H; Tochiki N; Takahashi A; Kataoka S; Okuda K; Liu Y; Fujii H; Umemura A; Moriguchi M; Okanoue T; Itoh Y Lab Invest; 2022 Mar; 102(3):281-289. PubMed ID: 34732847 [TBL] [Abstract][Full Text] [Related]
39. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. Luukkonen PK; Zhou Y; Sädevirta S; Leivonen M; Arola J; Orešič M; Hyötyläinen T; Yki-Järvinen H J Hepatol; 2016 May; 64(5):1167-1175. PubMed ID: 26780287 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis. Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]